Net Profit Margin
since 2005
Calculation
Johnson & Johnson, net profit margin, long-term trends, calculation
| Net profit margin | = | 100 | × | Net earnings1 | ÷ | Sales to customers1 | |
|---|---|---|---|---|---|---|---|
| Dec 28, 2025 | 28.46% | = | 100 | × | 26,804) | ÷ | 94,193) |
| Dec 29, 2024 | 15.84% | = | 100 | × | 14,066) | ÷ | 88,821) |
| Dec 31, 2023 | 41.28% | = | 100 | × | 35,153) | ÷ | 85,159) |
| Dec 31, 2022 | 18.90% | = | 100 | × | 17,941) | ÷ | 94,943) |
| Dec 31, 2021 | 22.26% | = | 100 | × | 20,878) | ÷ | 93,775) |
| Dec 31, 2020 | 17.82% | = | 100 | × | 14,714) | ÷ | 82,584) |
| Dec 29, 2019 | 18.42% | = | 100 | × | 15,119) | ÷ | 82,059) |
| Dec 30, 2018 | 18.75% | = | 100 | × | 15,297) | ÷ | 81,581) |
| Dec 31, 2017 | 1.70% | = | 100 | × | 1,300) | ÷ | 76,450) |
| Dec 31, 2016 | 23.01% | = | 100 | × | 16,540) | ÷ | 71,890) |
| Dec 31, 2015 | 21.99% | = | 100 | × | 15,409) | ÷ | 70,074) |
| Dec 28, 2014 | 21.96% | = | 100 | × | 16,323) | ÷ | 74,331) |
| Dec 29, 2013 | 19.40% | = | 100 | × | 13,831) | ÷ | 71,312) |
| Dec 30, 2012 | 16.14% | = | 100 | × | 10,853) | ÷ | 67,224) |
| Dec 31, 2011 | 14.87% | = | 100 | × | 9,672) | ÷ | 65,030) |
| Dec 31, 2010 | 21.65% | = | 100 | × | 13,334) | ÷ | 61,587) |
| Dec 31, 2009 | 19.82% | = | 100 | × | 12,266) | ÷ | 61,897) |
| Dec 28, 2008 | 20.31% | = | 100 | × | 12,949) | ÷ | 63,747) |
| Dec 30, 2007 | 17.31% | = | 100 | × | 10,576) | ÷ | 61,095) |
| Dec 31, 2006 | 20.73% | = | 100 | × | 11,053) | ÷ | 53,324) |
| Dec 31, 2005 | 20.61% | = | 100 | × | 10,411) | ÷ | 50,514) |
Based on: 10-K (reporting date: 2025-12-28), 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
The net profit margin exhibited considerable fluctuation over the period from 2005 to 2025. Initially, the margin demonstrated relative stability, followed by a period of volatility and a significant peak in recent years. A detailed examination reveals distinct phases in its performance.
- Initial Stability & Decline (2005-2007)
- From 2005 to 2006, the net profit margin remained consistently high, fluctuating between 20.61% and 20.73%. However, a noticeable decline occurred in 2007, dropping to 17.31%. This represents the first significant deviation from the prior trend.
- Recovery & Peak (2008-2016)
- The margin recovered in 2008, reaching 20.31%, and continued to trend upwards, peaking at 23.01% in 2016. This period indicates a strong ability to translate sales into profit. The years 2014 through 2016 show particularly strong and consistent performance, with margins exceeding 21.9% each year.
- Dramatic Decline & Recovery (2017-2019)
- A substantial and abrupt decrease in net profit margin was observed in 2017, falling to a low of 1.70%. While the margin recovered somewhat in the following two years, reaching 18.75% and 18.42% in 2018 and 2019 respectively, it did not return to the levels seen prior to 2017. This suggests a significant disruption to profitability in 2017, the cause of which would require further investigation.
- Recent Volatility & Peak (2020-2025)
- The period from 2020 to 2025 demonstrates increased volatility. The margin rose to 22.26% in 2020, decreased to 18.90% in 2021, then experienced a dramatic increase to 41.28% in 2022. This was followed by a decrease to 15.84% in 2023 and a further increase to 28.46% in 2025. The substantial increase in 2022 warrants further scrutiny to understand the underlying drivers. The most recent value suggests a return to a higher level of profitability, but remains below the peak observed in 2022.
Overall, the net profit margin has demonstrated a complex pattern over the analyzed timeframe. While periods of strong profitability were evident, significant fluctuations, particularly in 2017 and 2022-2025, indicate potential areas for further financial investigation.
AI Ask an analyst for more
Comparison to Competitors
Johnson & Johnson, net profit margin, long-term trends, comparison to competitors
| Johnson & Johnson | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 28, 2025 | 28.46% | 6.91% | 21.94% | 14.64% | 14.71% | 31.67% | 29.43% | 28.08% | 12.42% | 31.41% | 15.05% | 32.94% |
| Dec 29, 2024 | 15.84% | 7.59% | 12.77% | -18.53% | 16.33% | 23.51% | 1.68% | 26.68% | 12.62% | 31.07% | 14.77% | -4.86% |
| Dec 31, 2023 | 41.28% | 8.95% | 24.96% | 17.83% | 19.94% | 15.36% | 21.03% | 0.61% | 3.56% | 30.14% | 13.99% | 36.68% |
| Dec 31, 2022 | 18.90% | 20.39% | 26.42% | 13.71% | 22.91% | 21.88% | 17.02% | 24.49% | 31.01% | 35.64% | 15.47% | 37.20% |
| Dec 31, 2021 | 22.26% | 20.54% | 24.25% | 15.08% | 21.84% | 19.71% | 23.05% | 26.79% | 26.76% | 50.25% | 19.70% | 30.92% |
| Dec 31, 2020 | 17.82% | 10.08% | 29.97% | -21.20% | 16.36% | 25.24% | 0.51% | 14.72% | 22.53% | 41.35% | 19.79% | 43.70% |
| Dec 29, 2019 | 18.42% | 23.69% | 35.32% | 13.15% | 16.80% | 37.27% | 24.35% | 21.01% | 31.45% | 26.91% | 14.47% | 28.27% |
| Dec 30, 2018 | 18.75% | 17.36% | 37.25% | 21.81% | 13.33% | 13.16% | 25.16% | 14.71% | 20.79% | 36.42% | 12.06% | 68.80% |
| Dec 31, 2017 | 1.70% | 18.82% | 9.08% | 4.85% | 13.60% | -0.89% | 18.03% | 5.97% | 40.55% | 20.41% | 10.64% | 10.59% |
| Dec 31, 2016 | 23.01% | 23.22% | 35.27% | 22.94% | 15.13% | 12.90% | 45.07% | 9.85% | 13.66% | 18.42% | 11.06% | -6.58% |
| Dec 31, 2015 | 21.99% | 22.50% | 33.13% | 9.45% | 16.33% | 12.07% | 56.32% | 11.25% | 14.25% | 15.50% | 11.64% | -53.89% |
| Dec 28, 2014 | 21.96% | 8.89% | 26.69% | 12.62% | 13.05% | 12.19% | 49.44% | 28.22% | 18.42% | 12.34% | 11.22% | -127.25% |
| Dec 29, 2013 | 19.40% | 21.97% | 27.93% | 15.64% | 14.10% | 20.27% | 28.46% | 10.00% | 42.65% | 20.16% | 9.73% | -36.72% |
| Dec 30, 2012 | 16.14% | 28.70% | 26.11% | 11.12% | 13.10% | 18.09% | 27.57% | 13.05% | 24.70% | 54.43% | 9.42% | -7.01% |
| Dec 31, 2011 | 14.87% | — | 24.08% | 17.46% | 13.50% | 17.90% | 34.60% | 13.05% | 14.84% | -49.74% | 11.34% | 2.10% |
| Dec 31, 2010 | 21.65% | — | 31.56% | 15.92% | 13.58% | 21.97% | 39.26% | 1.87% | 12.18% | -22.76% | 9.60% | -526.35% |
| Dec 31, 2009 | 19.82% | — | 32.09% | 56.42% | 10.30% | 19.82% | 40.74% | 47.04% | 17.27% | -17.88% | 8.41% | -630.27% |
| Dec 28, 2008 | 20.31% | — | 28.57% | 25.47% | 10.38% | -10.17% | 39.55% | 32.74% | 16.78% | -34.69% | 9.47% | -262.02% |
| Dec 30, 2007 | 17.31% | — | 22.12% | 11.19% | 12.42% | 15.85% | 43.27% | 13.54% | 16.82% | -84.46% | 7.81% | -196.61% |
| Dec 31, 2006 | 20.73% | — | 21.29% | 8.85% | 11.69% | 16.97% | -45.98% | 19.59% | 39.98% | -161.30% | 4.46% | -95.63% |
| Dec 31, 2005 | 20.61% | — | 30.56% | 15.62% | 11.24% | 13.52% | 44.99% | 21.04% | 15.76% | -144.19% | 8.48% | -126.43% |
Based on: 10-K (reporting date: 2025-12-28), 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Johnson & Johnson, net profit margin, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Johnson & Johnson | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Dec 28, 2025 | 28.46% | 21.54% |
| Dec 29, 2024 | 15.84% | 12.30% |
| Dec 31, 2023 | 41.28% | 17.95% |
| Dec 31, 2022 | 18.90% | 22.55% |
| Dec 31, 2021 | 22.26% | 23.38% |
| Dec 31, 2020 | 17.82% | 14.07% |
| Dec 29, 2019 | 18.42% | 23.22% |
| Dec 30, 2018 | 18.75% | 19.82% |
| Dec 31, 2017 | 1.70% | 13.06% |
| Dec 31, 2016 | 23.01% | 20.78% |
| Dec 31, 2015 | 21.99% | 21.17% |
| Dec 28, 2014 | 21.96% | 21.24% |
| Dec 29, 2013 | 19.40% | 21.99% |
| Dec 30, 2012 | 16.14% | 18.53% |
| Dec 31, 2011 | 14.87% | 15.70% |
| Dec 31, 2010 | 21.65% | 15.16% |
| Dec 31, 2009 | 19.82% | 25.73% |
| Dec 28, 2008 | 20.31% | 18.17% |
| Dec 30, 2007 | 17.31% | 15.90% |
| Dec 31, 2006 | 20.73% | 22.24% |
| Dec 31, 2005 | 20.61% | 18.33% |
Based on: 10-K (reporting date: 2025-12-28), 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Johnson & Johnson, net profit margin, long-term trends, comparison to industry (health care)
| Johnson & Johnson | Health Care | |
|---|---|---|
| Dec 28, 2025 | 28.46% | 11.79% |
| Dec 29, 2024 | 15.84% | 8.84% |
| Dec 31, 2023 | 41.28% | 11.49% |
| Dec 31, 2022 | 18.90% | 14.65% |
| Dec 31, 2021 | 22.26% | 15.24% |
| Dec 31, 2020 | 17.82% | 10.27% |
| Dec 29, 2019 | 18.42% | 14.56% |
| Dec 30, 2018 | 18.75% | 12.61% |
| Dec 31, 2017 | 1.70% | 9.26% |
| Dec 31, 2016 | 23.01% | 12.80% |
| Dec 31, 2015 | 21.99% | 13.94% |
| Dec 28, 2014 | 21.96% | 14.40% |
| Dec 29, 2013 | 19.40% | 15.04% |
| Dec 30, 2012 | 16.14% | 13.92% |
| Dec 31, 2011 | 14.87% | 12.06% |
| Dec 31, 2010 | 21.65% | 11.90% |
| Dec 31, 2009 | 19.82% | 17.77% |
| Dec 28, 2008 | 20.31% | 13.00% |
| Dec 30, 2007 | 17.31% | 12.52% |
| Dec 31, 2006 | 20.73% | 15.30% |
| Dec 31, 2005 | 20.61% | 14.61% |
Based on: 10-K (reporting date: 2025-12-28), 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).